Search

everythinglearnresearchcommunity

for

Search:↓

Alopecia Areata affects both patients and their cohabitants' quality of life and emotional well-being.

JAK inhibitors for alopecia areata are linked to minor side effects like headache and acne, but not to an increased risk of serious adverse events.

Eight people with severe hair loss grew their hair back naturally.

Alopecia is not a significant predictor of thyroid disease when age and sex are considered.

Deuruxolitinib effectively improves hair regrowth in alopecia areata but requires monitoring for side effects.

Alopecia areata negatively impacts quality of life and work, even with moderate hair loss.

Patients and clinicians generally agree on eyebrow and eyelash hair loss improvements in severe alopecia areata.

Higher CD8+ T cell levels are linked to Alopecia areata in Iraqi patients.

Tofacitinib is effective and safe for treating alopecia areata with a good drug survival rate.

Patients with alopecia areata use social media for information but trust their doctors more.

Patients with alopecia areata may have lower vitamin D levels than healthy people.

Higher IL-15 levels are linked to more severe hair loss in alopecia areata.

Stress can trigger or worsen alopecia areata.

Early onset, severe types, nail changes, family history, and body hair loss worsen alopecia areata prognosis; sticking to treatment helps.

Most men prefer keeping their eyebrows over scalp hair.

Tofacitinib improved hair loss and skin symptoms in a patient after secukinumab caused hair loss.

Baricitinib helps improve hair growth in severe alopecia, with better results in less severe cases and higher doses working faster.

Corticosteroids are the most common treatment for alopecia areata, but many patients need better options.

Scalp rolling might help regrow hair in people with a hair loss condition called Alopecia Areata.

Alopecia Areata significantly reduces quality of life, especially in women, long-term sufferers, and severe cases.

The paper concludes that the new medication baricitinib needs further testing in a more diverse group of patients with alopecia areata.

Alopecia Areata greatly affects the quality of life and mental health of Canadian patients and their caregivers.

Both platelet-rich plasma and low-level laser therapy effectively treat hair loss with minimal side effects and good cost-benefit ratio.

Alopecia areata mainly affects men aged 21-40 and is linked to autoimmune issues, thyroid problems, and inflammation.

A woman with alopecia regrew her hair after taking a higher dose of tocilizumab.

Tofacitinib helps hair regrowth in alopecia areata but relapse is common after stopping treatment.

Patients with alopecia areata have higher levels of certain immune markers, suggesting new treatment targets.

Alopecia areata causes significant psychological distress in cancer patients, needing integrated care.

Negative illness perceptions increase emotional distress, worsening OCD symptoms in alopecia areata patients.

Hypnotherapy helps reduce or eliminate alopecia areata symptoms in children.